Tailored thrombolytic therapy: A perspective

68Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Background. In contrast with current standard regimens, it seems more appropriate to tailor thrombolytic therapy to individual patient characteristics. A proposed model for such tailored therapy is based on individual assessment of benefits and risks of thrombolytic therapy, taking into account the response of individual patients to the therapy given. Methods and Results. Potential benefits of thrombolysis in individual patients can be predicted by use of demographic patient characteristics (age, sex, history of previous infarction) together with indicators of the ischemic area at risk (total ST segment deviation) and treatment delay. Using these parameters, the number of "lives saved" by thrombolytic therapy for specific patient characteristics can be estimated. Similarly, the risk of intracranial hemorrhage during thrombolytic therapy can be estimated from the patient's age, blood pressure at admission, and body weight. Depending on benefit/risk estimates, a choice can be made between regimens with high, medium, or modest thrombolytic efficacy. Continuous multilead ECG ischemia monitoring and rapid assays of myocardial proteins in serum can be used to assess the occurrence or absence of reperfusion and to detect signs of reocclusion. Such data help to decide whether thrombolytic therapy should be continued or intensified or might be discontinued in individual patients before the total standard dose has been administered. Such tailored reduction of the total thrombolytic dose will reduce the risk for bleeding complications in some of the patients. Conclusions. The concept of tailoring thrombolytic therapy and the models presented for benefit/risk assessment should be tested in clinical studies and may subsequently help the physician to select the optimal approach in individual patients.

Author supplied keywords

Cited by Powered by Scopus

Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour

1139Citations
N/AReaders
Get full text

ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

974Citations
N/AReaders
Get full text

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: Results from an international trial of 9461 patients

869Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Simoons, M. L., & Arnold, A. E. R. (1993). Tailored thrombolytic therapy: A perspective. Circulation, 88(6), 2556–2564. https://doi.org/10.1161/01.cir.88.6.2556

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

44%

Researcher 3

33%

Professor / Associate Prof. 2

22%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

77%

Neuroscience 1

8%

Engineering 1

8%

Agricultural and Biological Sciences 1

8%

Save time finding and organizing research with Mendeley

Sign up for free